ES401603A1 - Procedimiento para la preparacion de agentes de contraste de rayos x. - Google Patents

Procedimiento para la preparacion de agentes de contraste de rayos x.

Info

Publication number
ES401603A1
ES401603A1 ES401603A ES401603A ES401603A1 ES 401603 A1 ES401603 A1 ES 401603A1 ES 401603 A ES401603 A ES 401603A ES 401603 A ES401603 A ES 401603A ES 401603 A1 ES401603 A1 ES 401603A1
Authority
ES
Spain
Prior art keywords
contrast agents
ray contrast
hydroxyacetamido
acetamido
physiologically compatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES401603A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES401603A1 publication Critical patent/ES401603A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES401603A 1971-04-10 1972-04-08 Procedimiento para la preparacion de agentes de contraste de rayos x. Expired ES401603A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2118219A DE2118219C3 (de) 1971-04-10 1971-04-10 Neues Röntgenkontrastmittel

Publications (1)

Publication Number Publication Date
ES401603A1 true ES401603A1 (es) 1975-02-16

Family

ID=5804754

Family Applications (1)

Application Number Title Priority Date Filing Date
ES401603A Expired ES401603A1 (es) 1971-04-10 1972-04-08 Procedimiento para la preparacion de agentes de contraste de rayos x.

Country Status (15)

Country Link
AT (2) AT316523B (xx)
AU (1) AU463194B2 (xx)
BE (1) BE781889A (xx)
CA (1) CA987339A (xx)
CH (1) CH574740A5 (xx)
DD (1) DD95265A5 (xx)
DE (1) DE2118219C3 (xx)
ES (1) ES401603A1 (xx)
FR (1) FR2132810B1 (xx)
GB (1) GB1391843A (xx)
HU (1) HU163446B (xx)
IL (1) IL39167A (xx)
IT (1) IT1048929B (xx)
NL (1) NL7204789A (xx)
ZA (1) ZA722396B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641682A5 (en) * 1978-10-05 1984-03-15 Daeniker Felix X-ray contrast medium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076024A (en) * 1954-02-19 1963-01-29 Sterling Drug Inc Acylated 3, 5-diaminopolyhalobenzoic acids
DE1129260B (de) * 1961-05-12 1962-05-10 Schering Ag Roentgenkontrastmittel

Also Published As

Publication number Publication date
DE2118219B2 (de) 1980-07-03
NL7204789A (xx) 1972-10-12
CA987339A (en) 1976-04-13
FR2132810A1 (xx) 1972-11-24
AT318801B (de) 1974-11-25
DE2118219A1 (de) 1972-10-26
FR2132810B1 (xx) 1975-03-14
HU163446B (xx) 1973-08-28
GB1391843A (en) 1975-04-23
DE2118219C3 (de) 1981-07-16
CH574740A5 (xx) 1976-04-30
AU4063372A (en) 1973-10-04
AT316523B (de) 1974-07-10
AU463194B2 (en) 1975-07-02
ZA722396B (en) 1972-12-27
IL39167A (en) 1976-01-30
IL39167A0 (en) 1972-06-28
BE781889A (fr) 1972-10-10
DD95265A5 (xx) 1973-01-20
IT1048929B (it) 1980-12-20

Similar Documents

Publication Publication Date Title
SE8402551D0 (sv) Cinnamoylmoranolin-derivat
LV5801A4 (lv) Omeprazola pievienotas bazes sali
IL40448A (en) Bis-imidazolium(or benzimidazolium)salts,their preparation and pharmaceutical compositions containing them
FR2285857A1 (fr) Agent de controle medical destine a etre administre par voie intravasculaire
CH541534A (fr) Préparation d'acide glyoxylique
ES460743A1 (es) Procedimiento para la obtencion de preparados medicinales con ph acido.
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
ES399609A1 (es) Procedimiento para la fabricacion de un polvo de producto lacteo acidificado.
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
ES401603A1 (es) Procedimiento para la preparacion de agentes de contraste de rayos x.
BE786497A (fr) Homologue superieur d'acide retinoique, ses sels et leur preparation
ES409333A1 (es) Procedimiento para la estabilizacion del bromo en una solu-cion acuosa.
ES428443A1 (es) Una dosis unitaria cardiotonica.
BE792803A (fr) Derives d'acide 8,12-diisoprostanoique optiquement actifs, leurpreparation et compositions en contenant
ES436179A1 (es) Procedimiento para intensificar la eficacia de medicamentos que in vivo o in vitro demuestren una afinidad de enlace a proteinas de la sangre.
IL40623A (en) 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them
ES294928A1 (es) Un procedimiento de preparar una composición líquida y estable de tetraciclina
IL34468A0 (en) Acid addition salts of indenopyridine derivatives,their preparation and pharmaceutical compositions containing them
ES393894A1 (es) Procedimiento para la obtencion de 1-metil-3- ((p-metil- alfa-fenil-bencil) oximetil) piperidina y sus sales de adi- cion y de amonio cuaternario.
GB1472816A (en) Circulatory pharmaceutical compositions containing tetrahydroal stonine
FR2042290A1 (en) Compositions containing uridine 5 diphospho- - glucose for treatment of liver disorders
ES370500A1 (es) Procedimiento para la preparacion de la hidracida.
GB1045969A (en) Sodium betaine aspartate
IL36985A (en) Pharmaceutical compositions containing acid addition salts of benzyl-(or beta-phenylethyl)-dimethylguanidine,certain such novel salts and their preparation
GB1023342A (en) A new iron salt and pharmaceutical compositions thereof